Physicians' Desk Reference 2003Medical professionals don't have to worry about missing the latest prescription drug developments throughout the year. "PDR Supplements" deliver every important update between annual editions of the PDR. |
From inside the book
Results 1-3 of 82
Page
... Intravenous ( Wyeth , 3387 ) . ..A325 Coreg Tablets ( GlaxoSmithKline , 1491 ) .... A164 Cordarone Tablets ( Wyeth , 3384 ) ... ..A321 Cardura Tablets ( Pfizer , 2581 ) . .A216 CASPOFUNGIN ACETATE AMOXICILLIN Cancidas for Injection ...
... Intravenous ( Wyeth , 3387 ) . ..A325 Coreg Tablets ( GlaxoSmithKline , 1491 ) .... A164 Cordarone Tablets ( Wyeth , 3384 ) ... ..A321 Cardura Tablets ( Pfizer , 2581 ) . .A216 CASPOFUNGIN ACETATE AMOXICILLIN Cancidas for Injection ...
Page A-263
... intravenous azithromycin have not been performed in older volunteers . Pharmacokinetics of azithromycin following oral adminis- tration in older volunteers ( 65-85 years old ) were similar to those in younger volunteers ( 18-40 years ...
... intravenous azithromycin have not been performed in older volunteers . Pharmacokinetics of azithromycin following oral adminis- tration in older volunteers ( 65-85 years old ) were similar to those in younger volunteers ( 18-40 years ...
Page A-280
... Intravenous : CellCept Intravenous is an alterna- tive dosage form to CellCept capsules , tablets and oral suspension recommended for patients unable to take oral CellCept . CellCept Intravenous should be administered within 24 hours ...
... Intravenous : CellCept Intravenous is an alterna- tive dosage form to CellCept capsules , tablets and oral suspension recommended for patients unable to take oral CellCept . CellCept Intravenous should be administered within 24 hours ...
Common terms and phrases
acid adults adverse events ADVERSE REACTIONS albuterol alprazolam anastrozole and/or approximately aripiprazole atomoxetine AVANDAMET AVONEX baseline candesartan cholesterol clearance CLINICAL PHARMACOLOGY clinical studies clinical trials Cmax CONTRAINDICATIONS COPEGUS daily dose decreased DEPAKOTE discontinued disease Disorders DOSAGE AND ADMINISTRATION double-blind Drug Interactions dutasteride effects efficacy eletriptan enalapril escitalopram evaluated excreted ezetimibe felodipine fenofibrate FORTEO GlaxoSmithKline glipizide heart failure hepatic HMG-CoA human dose HUMIRA hypertension impairment incidence increased inhibitors intravenous LAMICTAL lamotrigine levels levofloxacin LEXAPRO liver losartan Lovenox Injection metabolism metabolite METAGLIP metformin mg/day mg/dL mg/kg mg/kg/day mg/m² occurred omeprazole pain patients receiving patients treated PEDIARIX pediatric patients PEGASYS pharmacokinetics placebo placebo-controlled plasma concentrations PRECAUTIONS Pregnancy PRILOSEC PULMICORT RESPULES rats Rebif recommended reduced renal function reported ribavirin risk rosiglitazone serum sodium SOMAVERT symptoms syringe System Table Tablets therapy tients tion treatment vaccine valproate VALTREX vial vitro weeks ZETIA zolmitriptan µg/mL